share_log

Piper Sandler Maintains Overweight on InspireMD, Raises Price Target to $4.5

Benzinga ·  Nov 2, 2023 15:58

Piper Sandler analyst Adam Maeder maintains InspireMD (NASDAQ:NSPR) with a Overweight and raises the price target from $3.5 to $4.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment